-
Thematic Analysis
Biosimilars through Physician's Lens - Strategic Intelligence
Since their introduction within the past few decades, biosimilars outrivaled biologics in reducing treatment costs and improving access to therapies for chronic conditions such as cancer, rheumatoid arthritis (RA), and diabetes. Nevertheless, while biosimilars are increasingly recognized for their clinical and economic benefits, their uptake has been slower than anticipated in some markets. The physician’s role in shaping the future of biosimilar use is undeniable, given their influence on prescribing practices and patient trust. In this report, GlobalData examines biosimilar...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.